Hetero Labs Limited Esomeprazole Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Esomeprazole Export Records India — #8 Exporter, 209 Shipments, $9.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Esomeprazole

India Pharmaceutical Trade Intelligence

$456.5M643 Suppliers147 CountriesHS 30049039

ExportsIndia → UNITED STATES24.4%India → CANADA19.6%

ImportsSPAIN → India$457.1K GERMANY → India$43.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Hetero Labs Limited — Esomeprazole Exporter #8 | $9.0M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Esomeprazole Exporter Profile

Indian Pharmaceutical Exporter · #8 for Esomeprazole · $9.0M export value · DGFT Verified

Hetero Labs Limited is the #8 Indian exporter of Esomeprazole with $9.0M in export value and 209 verified shipments. Hetero Labs Limited holds a 2.0% market share in Esomeprazole exports across 13 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Esomeprazole Export Profile: Buyers & Destinations

Hetero Labs Limited Esomeprazole export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Esomeprazole?

Country	Value	Shipments	Share
CHILE	$3.3M	87	58.1%
SAUDI ARABIA	$1.8M	79	31.5%
UNITED ARAB EMIRATES	$323.2K	26	5.7%
VIETNAM, DEMOCRATIC REP. OF	$100.0K	2	1.8%
GUATEMALA	$65.6K

Who Are the Top Buyers of Esomeprazole from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	CHILE	$2.3M	97
SAUDI AMAROX FOR INDUSTRY COMPANY	SAUDI ARABIA	$1.0M	39
SEVEN PHARMA CHILE SPA	CHILE	$745.4K	15
TO THE ORDER	CHILE	$431.3K	12
TO THE ORDER OF.,	BRAZIL	$344.6K	11
BIOVENTURE HEALTHCARE-FZE	UNITED ARAB EMIRATES	$139.5K	10
M/S.	CHILE	$118.0K	3
TO THE ORDER OF.	KYRGHYSTAN	$106.0K	3
M S TO THE ORDER OF - SEVEN PHARMA	CHILE	$92.8K	2
SEVEN PHARMA GUATEMALA S.A.	GUATEMALA	$65.6K	2

Hetero Labs Limited supplies Esomeprazole to 23 buyers globally. The largest buyer is TO THE ORDER OF (CHILE), followed by SAUDI AMAROX FOR INDUSTRY COMPANY (SAUDI ARABIA) and SEVEN PHARMA CHILE SPA (CHILE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Esomeprazole Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
ESOPOLE ESOMEPRAZOLE CAPSULE	$670.2K	33
ESOMEPRAZOL ESOMEPRAZOLE CAPSULE	$538.9K	16
ESOMEPRAZOLE CAPSULE	$533.9K	14
ESOPOLE 20 (ESOMEPRAZOLE 20MG CAPSULE)	$254.8K	6
ESOPOLE 20 ESOMEPRAZOLE 20MG CAPSULE 28S	$250.0K	5
ESOMEPRAZOL ESOMEPRAZOLE CAPSULE 30S	$200.0K	4
ESOMEPRAZOL (ESOMEPRAZOLE CAPSULE )NOS	$150.0K	3
ESOMEPRAZOLE 40MG CAPSULE 30S (QTY-149,472 PAC)NOS	$150.0K	3
ESOPOLE ESOMEPRAZOLE CAPSULE	$136.2K	4
GERDIL ESOMEPRAZOLE CAPSULENOS	$111.8K	9

Hetero Labs Limited exports 74 distinct Esomeprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ESOPOLE ESOMEPRAZOLE CAPSULE with 33 shipments worth $670.2K.

How Does Hetero Labs Limited Compare to Nearest Esomeprazole Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	TORRENT PHARMACEUTICALS LTD	$9.8M	259	22	$38.0K
7	BIOCON PHARMA LIMITED	$9.4M	188	1	$49.9K
8	HETERO LABS LIMITED ★	$9.0M	209	13	$43.2K
3	MYLAN LABORATORIES LIMITED	$8.9M	179	6	$50.0K
9	ANNORA PHARMA PRIVATE LIMITED	$5.7M	155	1	$36.6K

Hetero Labs Limited ranks #8 among 643 Indian Esomeprazole exporters. Average shipment value of $43.2K compared to the market average of $323.1K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and BIOCON PHARMA LIMITED.

Which Indian Ports Ship Esomeprazole Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	829	8.7%
SAHAR AIR	824	8.6%
SAHAR AIR CARGO ACC (INBOM4)	707	7.4%
DELHI AIR CARGO ACC (INDEL4)	630	6.6%
DELHI AIR	522	5.5%
JNPT/ NHAVA SHEVA SEA	393	4.1%
JNPT	361	3.8%
CMA CGM LOGISTICS PARK ICD	305	3.2%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Esomeprazole Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Esomeprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 209 individual customs records matching Hetero Labs Limited exporting Esomeprazole, covering 74 formulations to 14 countries via 23 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 147+ countries, 1,634+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Esomeprazole

Esomeprazole

Hetero Labs Limited — Esomeprazole Exporter Profile

Hetero Labs Limited — Esomeprazole Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Esomeprazole?

Who Are the Top Buyers of Esomeprazole from Hetero Labs Limited?

What Is India's Total Esomeprazole Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Esomeprazole Exports?

How Does Hetero Labs Limited Compare to Other Indian Esomeprazole Exporters?

What Esomeprazole Formulations Does Hetero Labs Limited Export?

How Does Hetero Labs Limited Compare to Nearest Esomeprazole Exporters?

Which Indian Ports Ship Esomeprazole Exports?

What Other Gastrointestinal Products Does Hetero Labs Limited Export?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Esomeprazole Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Esomeprazole Export Data from Hetero Labs Limited

Esomeprazole Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source